000 | 01306 a2200313 4500 | ||
---|---|---|---|
005 | 20250514214302.0 | ||
264 | 0 | _c20050526 | |
008 | 200505s 0 0 eng d | ||
022 | _a0009-8981 | ||
024 | 7 |
_a10.1016/j.cccn.2004.09.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCosta, Lucio G | |
245 | 0 | 0 |
_aMeasurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. _h[electronic resource] |
260 |
_bClinica chimica acta; international journal of clinical chemistry _cFeb 2005 |
||
300 |
_a37-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAryldialkylphosphatase _xchemistry |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeurotoxicity Syndromes _xenzymology |
650 | 0 | 4 |
_aOrganophosphates _xtoxicity |
700 | 1 | _aCole, Toby B | |
700 | 1 | _aVitalone, Annabella | |
700 | 1 | _aFurlong, Clement E | |
773 | 0 |
_tClinica chimica acta; international journal of clinical chemistry _gvol. 352 _gno. 1-2 _gp. 37-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cccn.2004.09.019 _zAvailable from publisher's website |
999 |
_c15332354 _d15332354 |